– IRELAND, Dublin – Shire plc (LSE: SHP, NASDAQ: SHPG), announces that Dominic Blakemore will join its Board of Directors effective 1 January 2014 as non executive director and member of the Audit, Compliance & Risk Committee.
Matthew Emmens, Chairman of Shire commented: “The Shire Board will benefit from Dominic’s strategic and financial experience. We look forward to him joining the Board.”
Dominic Blakemore added: “Shire has an excellent track record of growth and a clear strategy. I look forward to playing a part in this growing company’s future.”
Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.